Spleen Hemi Splenectomy
Spleen Hemi Splenectomy - Related Videos
08:34
Robot-assisted Partial Splenectomy
0 Views •
2026
This protocol describes a robot-assisted partial splenectomy for a benign splenic tumor. The robotic approach optimizes spleen preservation by enhancing surgical precision, minimizing blood loss, and improving postoperative outcomes. Key surgical steps include meticulous splenic hilum dissection, selective vascular ligation, intraoperative ultrasonography, and controlled parenchymal transection.
10:13
Hemi-laryngeal Setup for Studying Vocal Fold Vibration in Three Dimensions
0 Views •
Cited by 12 •
2017
This paper introduces a protocol for the preparation of hemi-larynx specimens facilitating a multi-dimensional view of vocal fold vibration, in order to investigate various biophysical aspects of voice production in humans and non-human mammals.
04:47
A Mouse Model of Vascularized Heterotopic Spleen Transplantation
0 Views •
2025
The video demonstrates a surgical method for generating a mouse model of vascularized heterotopic spleen transplantation. The abdominal cavity of an anesthetized donor mouse is surgically opened to remove the spleen. The inferior vena cava and infrarenal aorta are identified, their lumbar branches are ligated, and openings are made for the heterotopic transplantation of a spleen from a congenic donor mouse. Upon completing vascular anastomosis and restoring blood flow to the implanted spleen,...
02:03
Assessing Bacterial Burden in the Mouse Spleen for Infection Studies
0 Views •
2026
Source: Madenspacher, J. H. and Fessler, M. B. A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice. J. Vis. Exp. (2016)This video demonstrates the process of quantifying bacterial load in the spleen of an infected mouse to assess the severity of infection. The homogenized spleen is serially diluted and plated to determine total bacterial burden. The resulting data provide insights into host-pathogen interactions within...
05:18
Preparation of Single-Cell Suspensions from Mouse Spleen with the gentleMACS Dissociator
0 Views •
Cited by 22 •
2008
This video describes a simple, time-saving technique for automated tissue dissociation using the gentleMACS Dissociator to prepare single-cell suspensions of mouse splenocytes.
FAQs
Selective vessel control separates the blood supply of the diseased or injured splenic portion from that of the tissue intended to remain. This allows surgeons to remove the affected segment while maintaining perfusion in viable parenchyma. The approach therefore depends on matching vascular division with the planned resection so that preserved tissue can continue functioning.
Keeping viable parenchyma preserves a portion of the spleen’s physiological activity rather than eliminating the organ entirely. That distinction is important when a problem is confined to one region, because removing only the affected tissue may address the local condition while limiting the consequences associated with complete spleen removal. The benefit depends on adequate remaining tissue.
The resection must remove the affected segment without compromising the remaining perfused tissue. After separation, the cut surface requires control to manage the operative division within the spleen. Careful coordination of these steps supports structural control while protecting the viable parenchyma that remains available for immune and hematologic activity.
This operation may be considered when disease or injury is localized to a splenic segment and complete removal can be avoided. The source material identifies localized splenic lesions, selected traumatic injuries, and other conditions requiring resection as potential contexts. Its relevance is greatest when the affected area can be removed while viable tissue remains.
The procedure proceeds by identifying the splenic region involved, isolating and dividing the vessels supplying that portion, and resecting the affected segment. Surgeons then control the splenic cut surface while preserving blood flow to the remaining tissue. This sequence links anatomical targeting, vascular management, tissue removal, and protection of residual parenchyma.
The technique balances removal of diseased or injured tissue against preservation of splenic activity. A successful approach addresses the localized problem, controls the resection surface, and maintains perfusion in the remaining parenchyma. Retaining that tissue may help sustain immune and hematologic functions while reducing the consequences associated with total spleen removal.